Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by WinterCon Oct 22, 2016 3:04pm
183 Views
Post# 25374489

RE:RE:RE:Impact of Ca., Nevada, Maine, Mass. and Arz. Nov. vote

RE:RE:RE:Impact of Ca., Nevada, Maine, Mass. and Arz. Nov. vote
The news said, "Under the terms of the agreement, MassRoots will help build awareness of the Aphria brand amongst its Canadian userbase.".

I could be wrong, just came to that conclusion after reading some state laws and Canadian MMJ export laws. 


https://www.hc-sc.gc.ca/dhp-mps/marihuana/info/licencedproducer-producteurautorise/import-eng.php

Canadian MMJ laws stated that, "Canada's international drug treaty obligations. As such, they are not a vehicle for supplying cannabis to foreign markets where recreational use is legal.", "Health Canada has an obligation to maintain control over the movement of cannabis in a manner consistent with these international drug control conventions which strictly limit trade in cannabis to medical and scientific purposes between countries with the International Narcotics Control".

This means that Aphria partnership with Australian company, CGC in Brazil and Germany is for medical and scientific purposes. They can trade MMJ but not recreational drugs due to international UN drug law. Which even takes one year to withdraw from. 

Only immediate MMJ benefits with US states but cannot profit from recreational side, unless you make a partnership with US based company, buyout or you build your facility in the US and obtain a state license.


Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse